These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31679079)

  • 1. Platelet aggregation is not altered among men with diabetes mellitus.
    Kring C; Rasmussen LM; Lindholt JS; Diederichsen ACP; Vinholt PJ
    Acta Diabetol; 2020 Apr; 57(4):389-399. PubMed ID: 31679079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Franchi F; Rollini F; Aggarwal N; Hu J; Kureti M; Durairaj A; Duarte VE; Cho JR; Been L; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2016 Sep; 134(11):780-92. PubMed ID: 27559041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
    Ueno M; Ferreiro JL; Desai B; Tomasello SD; Tello-Montoliu A; Capodanno D; Capranzano P; Kodali M; Dharmashankar K; Charlton RK; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis.
    Vinholt PJ; Hvas AM; Nielsen C; Söderström AC; Sprogøe U; Fialla AD; Nybo M
    Platelets; 2018 Jul; 29(5):520-527. PubMed ID: 28895774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
    Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
    Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry).
    Silvain J; Abtan J; Kerneis M; Martin R; Finzi J; Vignalou JB; Barthélémy O; O'Connor SA; Luyt CE; Brechot N; Mercadier A; Brugier D; Galier S; Collet JP; Chastre J; Montalescot G
    J Am Coll Cardiol; 2014 Apr; 63(13):1289-1296. PubMed ID: 24361322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Artery Calcium Score Compared with Cardio-Ankle Vascular Index in the Prediction of Cardiovascular Events in Asymptomatic Patients with Type 2 Diabetes.
    Chung SL; Yang CC; Chen CC; Hsu YC; Lei MH
    J Atheroscler Thromb; 2015; 22(12):1255-65. PubMed ID: 26269147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D diminishes the high platelet aggregation of type 2 diabetes mellitus patients.
    Sultan M; Twito O; Tohami T; Ramati E; Neumark E; Rashid G
    Platelets; 2019; 30(1):120-125. PubMed ID: 29313404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus.
    Antonopoulou S; Fragopoulou E; Karantonis HC; Mitsou E; Sitara M; Rementzis J; Mourelatos A; Ginis A; Phenekos C
    J Med Food; 2006; 9(3):356-62. PubMed ID: 17004898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DanCavas Pilot Study of Multifaceted Screening for Subclinical Cardiovascular Disease in Men and Women Aged 65-74 Years.
    Kvist TV; Lindholt JS; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Olsen MH; Mickley H; Hallas J; Urbonaviciene G; Busk M; Egstrup K; Diederichsen ACP
    Eur J Vasc Endovasc Surg; 2017 Jan; 53(1):123-131. PubMed ID: 27890524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    PLoS One; 2015; 10(5):e0126767. PubMed ID: 25993271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
    Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
    Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of multiple electrode aggregometry and light transmittance aggregometry in stable cardiovascular patients with type 2 diabetes mellitus.
    Tsantes AE; Taichert M; Kyriakou E; Katogiannis K; Lytras T; Gialeraki A; Tzoumakidou E; Kokoris S; Douramani P; Kypraiou A; Poulis A; Katsadiotis G; Kalantzis D; Kottaridi C; Kopterides P; Bonovas S; Ikonomidis I
    Thromb Res; 2019 Aug; 180():47-54. PubMed ID: 31202191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.